Literature DB >> 8485304

Analysis of enteropathy induced by tumour necrosis factor alpha.

P Garside1, C Bunce, R C Tomlinson, B L Nichols, A M Mowat.   

Abstract

Tumour necrosis factor (TNF)-alpha has been implicated in the pathogenesis of experimental and clinical enteropathy, but its exact role is unknown. We show here that a single dose of TNF-alpha causes significant small intestinal pathology in normal adult mice, which develops within 15 minutes, persists for up to 48 hours and is enhanced by interferon-gamma (IFN-gamma). The enteropathy consists of villus atrophy and crypt hyperplasia and is therefore similar to that found in immunologically mediated enteropathies such as graft-versus-host reaction (GvHR). TNF-alpha is also cytotoxic to an intestinal crypt cell line in vitro. Thus, a direct action of TNF-alpha on crypt cells may be involved in its enteropathic effects in vivo. Together, these findings indicate that TNF-alpha alone, or in concert with other cytokines, may be an important effector molecule in immunologically mediated intestinal pathology and may ultimately provide a target for specific immunotherapy for clinical enteropathies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485304     DOI: 10.1016/1043-4666(93)90020-6

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

Review 1.  Cytokines in experimental colitis.

Authors:  P Garside
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha.

Authors:  L Mahraoui; M Heyman; O Plique; M T Droy-Lefaix; J F Desjeux
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Transmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infection.

Authors:  M X Ierna; H E Scales; C Mueller; C E Lawrence
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 4.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

5.  Atg14 protects the intestinal epithelium from TNF-triggered villus atrophy.

Authors:  Haerin Jung; J Steven Leal-Ekman; Qiuhe Lu; Thaddeus S Stappenbeck
Journal:  Autophagy       Date:  2019-04-03       Impact factor: 16.016

6.  Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intestinal pathology.

Authors:  Neil Foster; Scott Hulme; Margaret Lovell; Katharine Reed; Paul Barrow
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Impaired rejection and mucosal injury of small intestinal allografts lacking the interferon-gamma receptor.

Authors:  Andrew M Veitch; Lisa M Higgins; Mona Bajaj-Elliot; Michael J G Farthing; Thomas T MacDonald
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

8.  Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis.

Authors:  Toshimitsu Yamaoka; Fang Yan; Hanwei Cao; Stuart S Hobbs; Rebecca S Dise; Wei Tong; D Brent Polk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-13       Impact factor: 11.205

9.  Effect of selective PKC isoform activation and inhibition on TNF-alpha-induced injury and apoptosis in human intestinal epithelial cells.

Authors:  Q Chang; B L Tepperman
Journal:  Br J Pharmacol       Date:  2003-09       Impact factor: 8.739

10.  Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.

Authors:  M Bajaj-Elliott; R Poulsom; S L Pender; N C Wathen; T T MacDonald
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.